JACC Heart Failure Editor's Update, November 2018
NOVEMBER 2018 JACC: HEART FAILURE
Right ventricular function has been studied extensively in recent years and is now seen as a strong predictor of mortality. Myriam Amsallem and colleagues discuss emerging data on right ventricular phenotyping and the results of clinical trials related to right ventricular failure, review options for mechanical support, and look at directions for future research. Click below to learn more about major research advances in this area in a State-of-the Art review:
Forgotten No More: A Focused Update on the Right Ventricle in Cardiovascular Disease
Myriam Amsallem, Olaf Mercier, et al
Are alpha blockers safe in heart failure patients? Cynthia Jackevicius et al present new data on this unresolved question. The current study shows they are not only safe but could also be a good treatment for comorbid conditions. Click below to read the results:
Safety of Alpha-Adrenergic Receptor Antagonists in Heart Failure
Cynthia A. Jackevicius, Zunera Ghaznavi, et al
Blood volume analysis is frequently used to guide care of acute heart failure patients. Is this an effective approach? John Strobeck and colleagues looked at possibilities for optimizing care by utilizing more precise and objective measurement and analysis of blood volume to guide treatment. For the results of this interesting analysis, click below:
Heart Failure Outcomes With Volume-Guided Management
John E. Strobeck, Jonathan Feldschuh, and Wayne L. Miller
LVAD destination implantation has an enormous impact on caregivers. What factors impact their decisions in considering LVADs for loved ones and how do they compare with patient decisions? Are there more effective ways that caregivers can participate in shared decision making? Colleen K. McIlvennan and colleagues provide important insights into the shared decision-making process, the role of the caregiver and tools to aid in decision making. Click below to learn more:
Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial
Colleen K. McIlvennan, Daniel D. Matlock, et al
MEET ASSOCIATE EDITOR G. Michael Felker
We rely on Associate Editor G. Michael Felker’s insight and expertise in all aspects of heart failure, particularly for research related to biomarkers and drug therapy.
G. Michael Felker, MD, MHS, is Professor of Medicine in the Division of Cardiology at Duke University Medical Center, and Chief of the Heart Failure Section at Duke University School of Medicine. He did his medical training at Duke, his internal medicine training at Johns Hopkins Hospital where he was chief resident, and his cardiology training at Duke. Dr. Felker has published over 270 peer reviewed articles and book chapters in the field of heart failure. He has served on the Executive and Steering Committees for multiple national and international clinical trials in heart failure. He directs the Advanced Heart Failure Fellowship Training Program at the Duke University School of Medicine.
He is an editorial board member or peer reviewer for multiple high-impact medical journals, including the New England Journal of Medicine, JAMA, Lancet, Circulation, and JACC, and co-editor of Heart Failure: A Companion to Braunwald’s Heart Disease, the leading heart failure textbook. His research focus is on clinical trials in acute and chronic heart failure and the use of biomarkers as diagnostic, prognostic, and therapeutic tools in heart failure.
3 Things People May Not Know about Me:
- I love to play the guitar and try to play at least a little every day—although I only play half as well as Jim Januzzi, he has spent at least 10 times more money on gear than I have, so I am better on a per dollar basis.
- I read books more than medical literature and usually have 3–4 books going at once. I am an excellent resource for book club selections.
- I am married to a better academic physician than I am, and we have 2 amazing kids who teach us new stuff every day—our dinner table is a great debate society/current events review on a nightly basis!
CALL FOR PAPERS
Focusing on the growing body of literature surrounding heart failure in women, JACC: Heart Failure is planning a special issue on this topic for March 2019. Learn more and submit your manuscript by November 30.